Saffron Therapeutics Private Limited, a active private limited company, was established on 10 July 2014 in Daskroi, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24233GJ2014PTC080089. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.50 M and a paid-up capital of ₹0.50 M.
It upholds a compliant status. Employing 1 professional, Its leadership includes Amit Singh (Director), Hiren Rameshchandra Patel (Director). Past directors included Omkarchandra Rikhabdas Maloo, Anilkumar Umraosingh Negi, Shalin Atulkumar Parikh. Its latest AGM occurred on 30 September 2025, with the balance sheet filed on 31 March 2025. It is based at 7Th Floor, 702, Times Square Arcade, Opp. Rambaug,, Nr. Ravija Plaza, Thaltej-Shilaj Road, Daskroi, Gujarat, 380059.
U24233GJ2014PTC080089
080089
10 July 2014
₹0.50 M
₹0.50 M
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Saffron Therapeutics Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Amit Singh | Director | 10 Jul 2014 | Current |
| Hiren Rameshchandra Patel | Director | 25 Nov 2014 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Irp/Rp/Liquidator | 31 Dec 2024 | Past |
| Pramod Abcsdd | Director | 06 Nov 2024 | Past |
| Pramod Abcsdd | Director | 30 May 2015 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2017 | Past |
| Pramod Abcsdd | Additional Director | 21 Dec 2015 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Saffron Therapeutics Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 56.16% increase. The company also saw a substantial fall in profitability, with a 31.02% decrease in profit. The company's net worth Soared by an impressive increase of 11.79%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Saffron Therapeutics had a public holding of 59.16%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Saffron Therapeutics has a workforce of 1 employees as of Mar 22, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Saffron Therapeutics, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Saffron Therapeutics's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Saffron Therapeutics Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records. was completed.
Progress on Saffron Therapeutics Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad. was documented.
Progress on Hiren Rameshchandra Patel was appointed as a Director was appointed as a Director on 25 Nov 2014 & has been associated with this company since 11 years 1 month . was documented.
Amit Singh was appointed as a Director was appointed as a Director on 10 Jul 2014 & has been associated with this company since 11 years 6 months . was recorded as a recent event.
Saffron Therapeutics Private Limited was registered on 10 Jul 2014 with Roc Ahmedabad & aged 11 years 6 months as per MCA records. was recorded as a recent event.
The CIN of Saffron Therapeutics Private Limited is U24233GJ2014PTC080089.
Saffron Therapeutics Private Limited is headquartered at 7Th Floor, 702, Times Square Arcade, Opp. Rambaug,, Nr. Ravija Plaza, Thaltej-Shilaj Road, Daskroi, Gujarat, 380059.
Saffron Therapeutics Private Limited was incorporated on 10 July 2014.
The current directors of Saffron Therapeutics Private Limited are
The primary industry of Saffron Therapeutics Private Limited is Trade.
Saffron Therapeutics Private Limited is unlisted.
The authorized capital of Saffron Therapeutics Private Limited is ₹0.50 M, and the paid-up capital is ₹0.50 M.
The compliance status of Saffron Therapeutics Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX